ULB Research ⤶ |
Description of the Unit | Projects of the Unit | Composition |
Collaborations of the Unit | Protected technologies | Publications | Skills |
Faculty of Pharmacy | Research Department Pharmacotherapy and Galenic Pharmacy
Interfaculty institutes | Institute of Research in Immunology
(Code: ULB396)
► Melt granulation - pelletisation | |
► Pharmaceutical preformulation | |
► Transnasal delivery of peptides and proteins: Nose-to-brain drug delivery | |
► Pharmaceutical development : Innovative Immediate release and controlled-release dosage forms for oral, parenteral and inhalation delivery of drugs. | |
► Novel methods of production of dosage forms (3D printing, etc.) | |
► In vivo evaluation in animal (mouse) and man (volounteers and patients) of oral, pulmonary and parenteral DDS. | |
► Targeted anticancer drug delivery systems (oral, parenteral, nasal and pulmonary administration) | |
► Delivery of peptides, proteins and monoclonal antibodies (oral, parenteral, nasal and pulmonary delivery) | |
► Parenteral and implantable drug delivery systems : biodegradable microspheres for controlled-drug delivery of drugs, Nanoparticulate parenteral suspensions and emulsions, Biodegradable implants. | |
► Synthesis and development of new excipients / carriers : Thermosenitive copolymers, cross-linked pectin, chitosan derivatives, Bioadhesive nanoparticles. | |
► Oral bioavailability enhancement of drugs (BCS II and IV) : Crystalline nanoparticles for solubility and dissolution rate enhancement ; Solid dispersions. | |
► Pulmonary drug delivery systems : Antiasthmatics, COPD, antifungal, antibiotics and anticancer drugs, peptides and proteins. New fillers and/or carriers for inhalation (DPIs). | |
► Matrix and film-coated solid dosage forms (monolithic ; multi-layer and compression-coated tablets ; multiple-units). |